Status:

COMPLETED

The Effect of a Combination of Orange- and Pomegranate Actives on Physical Fitness in Elderly People

Lead Sponsor:

BioActor

Conditions:

Fitness

Eligibility:

All Genders

60-75 years

Phase:

NA

Brief Summary

The primary objective of this study is to determine the effect of daily supplementation of a combined orange- and pomegranate extract for a period of 4 weeks on physical fitness compared to placebo. ...

Detailed Description

Dietary habits and physical activity are two important components of a healthy lifestyle. Targeted nutritional interventions may improve health and stimulate physical activity. Both orange extracts an...

Eligibility Criteria

Inclusion

  • 60 - 75 years old
  • non smoking
  • BMI 18 -28 kg/m²

Exclusion

  • Allergy to test product/placebo or citrus fruits
  • BMI lower than 18 or higher than 28
  • Recent muscle injury in less than one month before the start of the study
  • Inability to perform the fitness tests
  • Medical conditions that might influence outcome measure or participant safety during testing, including but not limited to: severe cardiovascular disease, cancer, Parkinson's disease. To be decided by PI.
  • High blood pressure (systolic ≥ 140 mmHg, diastolic ≥ 90 mmHg)
  • Use of medication that may interfere with the study results, use of beta-blockers
  • Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study
  • Abuse of products; alcohol (\> 20 alcoholic units per week) and drugs

Key Trial Info

Start Date :

June 25 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 17 2019

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT03781999

Start Date

June 25 2018

End Date

January 17 2019

Last Update

June 24 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BioActor

Maastricht, Netherlands, 6229GS